EUVIMEDEUVIMED entdecken
Crossref

Dual-drug carboxymethyl chitosan hydrogel: Development, characterization, and in vitro evaluation for periodontal therapy

Büşra Yılmaz, Yeliz Yıldırım, Nil Yakar, Güven Özdemir, Alpdogan Kantarci, Gülnur Emingil

Carbohydrate Polymers · 2025-09 · 363 · 123726

DOI: 10.1016/j.carbpol.2025.123726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carbohydrate Polymers, 2025-09. Verfasst von Büşra Yılmaz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Department of Periodontology, Ege University, Izmir, Turkey. Hauptthemen laut MEDLINE: Chitosan, Hydrogels, Anti-Bacterial Agents, Doxycycline. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Ege University Research Foundation, Ege Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dual-drug delivery systems offer a novel approach to overcoming the complex challenges of periodontal disease treatment. This study aimed to develop and evaluate a carboxymethyl chitosan-based hydrogel incorporating doxycycline and atorvastatin for local delivery in periodontal therapy. The hydrogel formulations were characterized through Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and electron microscopy to assess their structural and physicochemical properties. The hydrogels were evaluated for drug loading efficiency and drug release profiles, antimicrobial activity, and cytotoxicity. The optimized formulation, containing 25 % atorvastatin and 75 % doxycycline, demonstrated a sustained and controlled release profile over 72 h, ensuring prolonged therapeutic effects. It exhibited significant antibacterial efficacy, particularly against Porphyromonas gingivalis, a keystone pathogen in periodontal disease, with inhibition zones reaching 54 ± 1.53 mm. Cytotoxicity assays on human keratinocyte cells (HaCaT) confirmed high biocompatibility, with over 97 % cell viability for the optimized formulation, whereas formulations with higher atorvastatin content exhibited increased cytotoxicity. These findings highlight the potential of this dual-drug hydrogel system as a promising localized treatment strategy for periodontal disease, offering controlled drug release, potent antimicrobial activity, and favorable biocompatibility. Future in vivo and clinical studies are warranted to validate its therapeutic efficacy and translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanHydrogelsAnti-Bacterial AgentsDoxycyclinePeriodontal DiseasesAtorvastatinDrug CarriersHumansPorphyromonas gingivalisDrug LiberationCell SurvivalCell LineMicrobial Sensitivity TestsKeratinocytesHaCaT Cells

Stichwörter der Autor:innen

AtorvastatinChitosanDoxycyclineDual-drug delivery systemsHydrogelsLocal drug deliveryPeriodontal disease

Substanzen

ChitosanHydrogelscarboxymethyl-chitosanAnti-Bacterial AgentsDoxycyclineAtorvastatinDrug Carriers

Autor:innen und Institutionen

  • Faculty of Dentistry, Department of Periodontology, Ege University, Izmir, Turkey.
  • Center for Drug R&D and Pharmacokinetic Applications (ARGEFAR), Ege University, Izmir, Turkey; Department of Chemistry, Faculty of Science, Ege University, Izmir, Turkey.
  • The ADA Forsyth Institute, Somerville, MA, USA; Faculty of Science, Department of Biology, Basic and Industrial Microbiology Section, Ege University, Izmir, Turkey.
  • Faculty of Science, Department of Biology, Basic and Industrial Microbiology Section, Ege University, Izmir, Turkey.
  • The ADA Forsyth Institute, Somerville, MA, USA; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA, USA; University of Minnesota, School of Dental Medicine, Department of…
  • İstinye University School of Dentistry, Department of Periodontology İstanbul, Turkey. Electronic address: gulnur.emingil@istinye.edu.tr.

Förderung

  • Ege University Research Foundation
  • Ege Üniversitesi

Zitieren

APA

Yılmaz, B., Yıldırım, Y., Yakar, N., Özdemir, G., Kantarci, A., & Emingil, G. (2025). Dual-drug carboxymethyl chitosan hydrogel: Development, characterization, and in vitro evaluation for periodontal therapy. Carbohydrate Polymers, 363, 123726. https://doi.org/10.1016/j.carbpol.2025.123726

Vancouver

Yılmaz B, Yıldırım Y, Yakar N, Özdemir G, Kantarci A, Emingil G. Dual-drug carboxymethyl chitosan hydrogel: Development, characterization, and in vitro evaluation for periodontal therapy. Carbohydrate Polymers. 2025;363:123726. doi:10.1016/j.carbpol.2025.123726

BibTeX
@article{Ylmaz2025,
  author = {Yılmaz, Büşra and Yıldırım, Yeliz and Yakar, Nil and Özdemir, Güven and Kantarci, Alpdogan and Emingil, Gülnur},
  title = {Dual-drug carboxymethyl chitosan hydrogel: Development, characterization, and in vitro evaluation for periodontal therapy},
  journal = {Carbohydrate Polymers},
  year = {2025},
  volume = {363},
  pages = {123726},
  doi = {10.1016/j.carbpol.2025.123726}
}
Kostenlos starten →